ZJYL
Jin Medical International Ltd.
Price Chart
Latest Quote
$2.47
-0.37 (-13.03%)
Current Price
| Previous Close | $2.84 |
| Open | $2.46 |
| Day High | $2.67 |
| Day Low | $2.41 |
| Volume | 37,515 |
Stock Information
| Shares Outstanding | 6.83M |
| Total Debt | $18.91M |
| Cash Equivalents | $29.63M |
| Revenue | $20.69M |
| Net Income | $1.19M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $19.33M |
| P/E Ratio | 12.35 |
| EPS (TTM) | $0.20 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $8.55M |
| Sales | $20.69M |
| Income | $1.19M |
| Book/sh | $3.79 |
| Cash/sh | $4.34 |
| Employees | 273 |
Financial Ratios
| Quick Ratio | 1.53 |
| Current Ratio | 1.85 |
| Debt/Eq | 63.95 |
| EPS Growth TTM | -32.00% |
Returns & Margins
| ROA | 0.77% |
| ROE | 4.75% |
| Gross Margin | 30.18% |
| Operating Margin | 9.83% |
| Profit Margin | 5.76% |
Ownership
| Insider Ownership | 86.95% |
| Institutional Ownership | 0.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.93 |
| P/B | 0.65 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.44 |
| SMA50 | $2.25 |
| SMA200 | $5.17 |
| RSI | 52.65 |
| ATR | 0.3650 |
| Shares Float | 891K |
| Short Float | 0.83% |
| Short Ratio | 1.37 |
| Volatility | 7.23 |
| Rel Volume | 0.04 |
Performance History
| Week | +10.27% |
| Month | +7.39% |
| Quarter | -15.41% |
| 6 Months | -47.67% |
| YTD | -45.11% |
| Year | -83.98% |
| 3 Years | -56.83% |
| 10 Years | -68.93% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $2.47 | 37,515 |
| 2026-06-04 | $2.86 | 100,800 |
| 2026-06-03 | $3.21 | 185,200 |
| 2026-06-02 | $3.25 | 15,845,400 |
| 2026-06-01 | $2.44 | 585,000 |
| 2026-05-29 | $2.24 | 5,800 |
| 2026-05-28 | $2.19 | 2,800 |
| 2026-05-27 | $2.18 | 6,000 |
| 2026-05-26 | $2.28 | 2,600 |
| 2026-05-22 | $2.38 | 3,800 |
| 2026-05-21 | $2.29 | 400 |
| 2026-05-20 | $2.28 | 0 |
| 2026-05-19 | $2.28 | 6,900 |
| 2026-05-18 | $2.38 | 800 |
| 2026-05-15 | $2.35 | 900 |
| 2026-05-14 | $2.46 | 4,500 |
| 2026-05-13 | $2.45 | 17,900 |
| 2026-05-12 | $2.45 | 6,100 |
| 2026-05-11 | $2.33 | 13,200 |
| 2026-05-08 | $2.12 | 3,500 |
| 2026-05-07 | $2.20 | 13,000 |
| 2026-05-06 | $2.30 | 17,300 |
About Jin Medical International Ltd.
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. It operates in the Mainland China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. operates as a subsidiary of Jolly Harmony Enterprises Limited.
đ° Latest News
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $14,642,741 | $13,999,241 | $13,036,623 | $12,992,023 |
| Cost Of Revenue | $14,642,741 | $13,999,241 | $13,036,623 | $12,992,023 |
| Total Revenue | $20,687,274 | $23,502,010 | $19,821,457 | $19,190,541 |
| Operating Revenue | $20,687,274 | $23,502,010 | $19,821,457 | $19,190,541 |
| Expenses | ||||
| Total Expenses | $20,079,092 | $19,863,262 | $16,954,195 | $17,060,017 |
| Other Income Expense | $198,565 | $78,442 | $171,993 | $430,509 |
| Other Non Operating Income Expenses | $175,494 | $105,216 | $222,399 | $244,115 |
| Net Non Operating Interest Income Expense | $789,070 | $466,524 | $182,682 | $181,605 |
| Operating Expense | $5,436,351 | $5,864,021 | $3,917,572 | $4,067,994 |
| Selling And Marketing Expense | $1,345,210 | $1,104,944 | $453,311 | $402,013 |
| General And Administrative Expense | $2,533,438 | $3,261,752 | $1,921,367 | $1,773,449 |
| Total Other Finance Cost | - | - | $-182,682 | $-181,605 |
| Interest Expense | - | - | - | - |
| Interest Expense Non Operating | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,191,297 | $3,675,927 | $2,878,230 | $2,706,527 |
| Net Interest Income | $789,070 | $466,524 | $182,682 | $181,605 |
| Interest Income | $789,070 | $466,524 | $182,682 | $181,605 |
| Normalized Income | $1,171,318 | $3,697,801 | $2,923,243 | $2,522,556 |
| Net Income From Continuing And Discontinued Operation | $1,191,297 | $3,675,927 | $2,878,230 | $2,706,527 |
| Total Operating Income As Reported | $608,182 | $3,638,748 | $2,867,262 | $2,130,524 |
| Net Income Common Stockholders | $1,191,297 | $3,675,927 | $2,878,230 | $2,706,527 |
| Net Income | $1,191,297 | $3,675,927 | $2,878,230 | $2,706,527 |
| Net Income Including Noncontrolling Interests | $1,381,245 | $3,419,835 | $2,878,230 | $2,706,527 |
| Net Income Continuous Operations | $1,381,245 | $3,419,835 | $2,878,230 | $2,706,527 |
| Pretax Income | $1,595,817 | $4,183,714 | $3,221,937 | $2,742,638 |
| Interest Income Non Operating | $789,070 | $466,524 | $182,682 | $181,605 |
| Operating Income | $608,182 | $3,638,748 | $2,867,262 | $2,130,524 |
| Gross Profit | $6,044,533 | $9,502,769 | $6,784,834 | $6,198,518 |
| Per Share | ||||
| Diluted EPS | - | $0.40 | $0.40 | $0.36 |
| Basic EPS | - | $0.40 | $0.40 | $0.36 |
| Other | ||||
| Tax Effect Of Unusual Items | $3,092 | $-4,900 | $-5,393 | $2,423 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $935,790 | $4,011,654 | $3,143,570 | $2,306,727 |
| Total Unusual Items | $23,071 | $-26,774 | $-50,406 | $186,394 |
| Total Unusual Items Excluding Goodwill | $23,071 | $-26,774 | $-50,406 | $186,394 |
| Reconciled Depreciation | $350,679 | $346,132 | $225,902 | $362,597 |
| EBITDA (Bullshit earnings) | $958,861 | $3,984,880 | $3,093,164 | $2,493,121 |
| EBIT | $608,182 | $3,638,748 | $2,867,262 | $2,130,524 |
| Diluted NI Availto Com Stockholders | $1,191,297 | $3,675,927 | $2,878,230 | $2,706,527 |
| Minority Interests | $-189,948 | $256,092 | $0 | $0 |
| Tax Provision | $214,572 | $763,879 | $343,707 | $36,111 |
| Gain On Sale Of Security | $23,071 | $-26,774 | $-50,406 | $186,394 |
| Research And Development | $1,557,703 | $1,497,325 | $1,542,894 | $1,892,532 |
| Selling General And Administration | $3,878,648 | $4,366,696 | $2,374,678 | $2,175,462 |
| Other Gand A | $2,533,438 | $3,261,752 | $1,921,367 | $1,773,449 |
| Diluted Average Shares | - | $7,823,707 | $7,256,849 | $7,500,000 |
| Basic Average Shares | - | $7,823,707 | $7,256,849 | $7,500,000 |
Fetched: 2026-06-02
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $28,535,920 | $27,668,356 | $23,824,741 | $15,072,478 |
| Total Assets | $53,368,358 | $45,800,769 | $32,903,450 | $20,939,534 |
| Total Non Current Assets | $9,225,145 | $2,984,553 | $1,787,635 | $2,036,387 |
| Non Current Deferred Assets | $141,801 | $121,322 | $152,475 | $245,212 |
| Non Current Deferred Taxes Assets | $141,801 | $121,322 | $152,475 | $245,212 |
| Goodwill And Other Intangible Assets | $1,102,802 | $1,146,828 | $154,364 | $163,213 |
| Other Intangible Assets | $1,102,802 | $1,146,828 | $154,364 | $163,213 |
| Current Assets | $44,143,213 | $42,816,216 | $31,115,815 | $18,903,147 |
| Current Deferred Assets | $153,753 | - | $0 | $701,396 |
| Prepaid Assets | $2,633,487 | $2,109,627 | $863,745 | $156,491 |
| Inventory | $4,923,164 | $5,173,458 | $5,053,136 | $6,724,415 |
| Receivables | $6,802,572 | $8,775,701 | $8,500,591 | $4,252,055 |
| Other Receivables | $152,173 | $215,402 | $28,852 | $131,449 |
| Taxes Receivable | $736,723 | $0 | - | - |
| Accounts Receivable | $5,913,676 | $8,458,393 | $4,231,215 | $4,084,349 |
| Allowance For Doubtful Accounts Receivable | $-153,197 | $-81,734 | $-125,448 | $-114,486 |
| Gross Accounts Receivable | $6,066,873 | $8,540,127 | $4,356,663 | $4,198,835 |
| Cash Cash Equivalents And Short Term Investments | $29,630,237 | $26,757,430 | $16,698,343 | $7,068,790 |
| Cash And Cash Equivalents | $7,461,630 | $8,136,179 | $6,929,508 | $4,792,632 |
| Cash Financial | $7,461,630 | $8,136,179 | $6,929,508 | $4,792,632 |
| Debt | ||||
| Net Debt | $11,375,838 | $3,186,261 | - | - |
| Total Debt | $18,910,113 | $11,603,769 | $4,113,000 | - |
| Long Term Debt And Capital Lease Obligation | $0 | $96,175 | $0 | - |
| Current Debt And Capital Lease Obligation | $18,910,113 | $11,507,594 | $4,113,000 | - |
| Current Debt | $18,837,468 | $11,322,440 | $4,113,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $23,795,891 | $17,248,309 | $8,924,345 | $5,703,843 |
| Total Non Current Liabilities Net Minority Interest | $0 | $96,175 | $0 | $0 |
| Current Liabilities | $23,795,891 | $17,152,134 | $8,924,345 | $5,703,843 |
| Current Deferred Liabilities | $611,233 | $797,077 | $829,219 | $830,305 |
| Payables And Accrued Expenses | $3,886,508 | $4,478,578 | $3,982,126 | $4,873,538 |
| Payables | $3,793,219 | $4,424,303 | $3,663,626 | $4,479,778 |
| Other Payable | $192,146 | $7,843 | - | - |
| Total Tax Payable | $302,317 | $1,123,573 | $271,423 | $248,090 |
| Income Tax Payable | $259,654 | $809,389 | $263,131 | $170,887 |
| Accounts Payable | $3,256,624 | $3,012,334 | $3,391,079 | $4,113,622 |
| Equity | ||||
| Common Stock Equity | $29,638,722 | $28,815,184 | $23,979,105 | $15,235,691 |
| Total Equity Gross Minority Interest | $29,572,467 | $28,552,460 | $23,979,105 | $15,235,691 |
| Stockholders Equity | $29,638,722 | $28,815,184 | $23,979,105 | $15,235,691 |
| Gains Losses Not Affecting Retained Earnings | $1,940,773 | $2,036,867 | $606,524 | $740,288 |
| Other Equity Adjustments | $1,940,773 | $2,036,867 | $606,524 | $740,288 |
| Retained Earnings | $20,940,978 | $20,021,346 | $16,927,605 | $14,408,843 |
| Other | ||||
| Ordinary Shares Number | $7,827,355 | $7,827,355 | $7,797,355 | $7,750,000 |
| Share Issued | $7,827,355 | $7,827,355 | $7,797,355 | $7,750,000 |
| Tangible Book Value | $28,535,920 | $27,668,356 | $23,824,741 | $15,072,478 |
| Invested Capital | $48,476,190 | $40,137,624 | $28,092,105 | $15,235,691 |
| Working Capital | $20,347,322 | $25,664,082 | $22,191,470 | $13,199,304 |
| Capital Lease Obligations | $72,645 | $281,329 | $0 | - |
| Total Capitalization | $29,638,722 | $28,815,184 | $23,979,105 | $15,235,691 |
| Minority Interest | $-66,255 | $-262,724 | $0 | - |
| Additional Paid In Capital | $6,749,144 | $6,749,144 | $6,437,179 | $79,810 |
| Capital Stock | $7,827 | $7,827 | $7,797 | $6,750 |
| Common Stock | $7,827 | $7,827 | $7,797 | $6,750 |
| Long Term Capital Lease Obligation | $0 | $96,175 | $0 | - |
| Current Deferred Revenue | $611,233 | $797,077 | $829,219 | $830,305 |
| Current Capital Lease Obligation | $72,645 | $185,154 | $0 | - |
| Line Of Credit | $18,837,468 | $11,322,440 | $4,113,000 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $388,037 | $368,885 | - | - |
| Current Accrued Expenses | $93,289 | $54,275 | $318,500 | $393,760 |
| Dueto Related Parties Current | $42,132 | $280,553 | $1,124 | $118,066 |
| Net PPE | $7,980,542 | $1,716,403 | $1,480,796 | $1,627,962 |
| Accumulated Depreciation | $-4,223,754 | $-4,133,190 | $-3,758,341 | $-3,658,722 |
| Gross PPE | $12,204,296 | $5,849,593 | $5,239,137 | $5,286,684 |
| Leases | $287,642 | $363,753 | $280,882 | $288,052 |
| Construction In Progress | $6,537,800 | $0 | - | - |
| Other Properties | $85,157 | $256,117 | - | - |
| Machinery Furniture Equipment | $2,839,492 | $2,737,062 | $2,561,736 | $2,540,931 |
| Buildings And Improvements | $2,454,205 | $2,492,661 | $2,396,519 | $2,457,701 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $915,839 | $1,367,421 | $820,949 | $2,050,597 |
| Work In Process | $1,910,478 | $1,745,523 | $1,613,781 | $1,399,074 |
| Raw Materials | $2,096,847 | $2,060,514 | $2,618,406 | $3,274,744 |
| Duefrom Related Parties Current | $0 | $101,906 | $4,240,524 | $36,257 |
| Other Short Term Investments | $22,168,607 | $18,621,251 | $9,768,835 | $2,276,158 |
Fetched: 2026-06-02
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-3,726,216 | $-2,331,537 | $2,992,466 | $1,540,490 |
| Operating Activities | ||||
| Operating Cash Flow | $2,903,584 | $-1,207,305 | $3,106,403 | $1,580,656 |
| Cash Flow From Continuing Operating Activities | $2,903,584 | $-1,207,305 | $3,106,403 | $1,580,656 |
| Operating Gains Losses | $-10,806 | $-42,414 | $-6,856 | - |
| Investing Activities | ||||
| Capital Expenditure | $-6,629,800 | $-1,124,232 | $-113,937 | $-40,166 |
| Investing Cash Flow | $-10,791,736 | $-9,514,007 | $-7,730,248 | $-120,904 |
| Cash Flow From Continuing Investing Activities | $-10,791,736 | $-9,514,007 | $-7,730,248 | $-120,904 |
| Net Other Investing Changes | - | - | - | $364,428 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $311,995 | $8,000,000 | $0 |
| Financing Cash Flow | $7,353,245 | $11,654,357 | $6,910,619 | $121,855 |
| Cash Flow From Continuing Financing Activities | $7,353,245 | $11,654,357 | $6,910,619 | $121,855 |
| Net Other Financing Charges | $-237,877 | $4,475,762 | $-5,680,019 | $121,855 |
| Net Common Stock Issuance | $0 | $311,995 | $8,000,000 | $0 |
| Common Stock Issuance | $0 | $311,995 | $8,000,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-11,431,057 | $-5,560,000 | $-1,418,000 | $0 |
| Issuance Of Debt | $19,022,179 | $12,426,600 | $5,672,000 | $0 |
| Interest Paid Supplemental Data | $411,068 | $239,369 | $5,319 | $0 |
| Income Tax Paid Supplemental Data | $564,795 | $205,373 | $142,730 | $47,438 |
| End Cash Position | $7,461,630 | $8,136,179 | $6,929,508 | $4,792,632 |
| Beginning Cash Position | $8,136,179 | $6,929,508 | $4,792,632 | $3,672,260 |
| Effect Of Exchange Rate Changes | $-139,642 | $273,626 | $-149,898 | $-461,235 |
| Changes In Cash | $-534,907 | $933,045 | $2,286,774 | $1,581,607 |
| Proceeds From Stock Option Exercised | $0 | $0 | $336,638 | $0 |
| Net Issuance Payments Of Debt | $7,591,122 | $6,866,600 | $4,254,000 | $0 |
| Net Short Term Debt Issuance | $7,591,122 | $6,866,600 | $4,254,000 | $0 |
| Short Term Debt Payments | $-11,431,057 | $-5,560,000 | $-1,418,000 | $0 |
| Short Term Debt Issuance | $19,022,179 | $12,426,600 | $5,672,000 | $0 |
| Net Investment Purchase And Sale | $-3,662,380 | $-8,390,123 | $-7,626,449 | $-445,166 |
| Sale Of Investment | $6,036,786 | $12,664,377 | $4,426,508 | $5,201,034 |
| Purchase Of Investment | $-9,699,166 | $-21,054,500 | $-12,052,957 | $-5,646,200 |
| Net Business Purchase And Sale | $-500,000 | $0 | $0 | - |
| Purchase Of Business | $-500,000 | $0 | $0 | - |
| Net Intangibles Purchase And Sale | $0 | $-979,283 | $0 | $0 |
| Purchase Of Intangibles | $0 | $-979,283 | $0 | $0 |
| Net PPE Purchase And Sale | $-6,629,356 | $-144,601 | $-103,799 | $-40,166 |
| Sale Of PPE | $444 | $348 | $10,138 | $0 |
| Purchase Of PPE | $-6,629,800 | $-144,949 | $-113,937 | $-40,166 |
| Change In Working Capital | $1,095,749 | $-4,919,672 | $-200,810 | $-1,431,388 |
| Change In Other Working Capital | $-171,322 | $-63,756 | $20,255 | $-755,371 |
| Change In Other Current Liabilities | $-144,132 | $-83,734 | $0 | $0 |
| Change In Payables And Accrued Expense | $-260,655 | $417,661 | $-684,071 | $-936,031 |
| Change In Accrued Expense | $245,925 | $97,208 | $-67,705 | $-281,189 |
| Change In Payable | $-506,580 | $320,453 | $-616,366 | $-654,842 |
| Change In Account Payable | $287,035 | $-499,570 | $-646,886 | $-810,342 |
| Change In Tax Payable | $-793,615 | $820,023 | $30,520 | $155,500 |
| Change In Income Tax Payable | $-793,615 | $820,023 | $30,520 | $155,500 |
| Change In Prepaid Assets | $-770,927 | $-1,362,669 | $-716,356 | $430,744 |
| Change In Inventory | $168,295 | $80,315 | $1,555,441 | $-504,387 |
| Change In Receivables | $2,274,490 | $-3,907,489 | $-376,079 | $333,657 |
| Changes In Account Receivables | $2,274,490 | $-3,907,489 | $-376,079 | $333,657 |
| Provisionand Write Offof Assets | $71,791 | $-47,515 | $120,334 | $28,943 |
| Asset Impairment Charge | $36,991 | $0 | $0 | - |
| Deferred Tax | $-22,065 | $36,329 | $89,603 | $-86,023 |
| Deferred Income Tax | $-22,065 | $36,329 | $89,603 | $-86,023 |
| Depreciation Amortization Depletion | $350,679 | $346,132 | $225,902 | $362,597 |
| Depreciation And Amortization | $350,679 | $346,132 | $225,902 | $362,597 |
| Amortization Cash Flow | $25,996 | $17,910 | $4,951 | $5,328 |
| Amortization Of Intangibles | $25,996 | $17,910 | $4,951 | $5,328 |
| Depreciation | $324,683 | $328,222 | $220,951 | $357,269 |
| Gain Loss On Investment Securities | $-47,500 | $-45,000 | - | - |
| Gain Loss On Sale Of PPE | $36,694 | $2,586 | $-6,856 | $0 |
| Net Income From Continuing Operations | $1,381,245 | $3,419,835 | $2,878,230 | $2,706,527 |
| Other Non Cash Items | - | - | - | - |
Fetched: 2026-06-02